Integer (NYSE:ITGR) Updates FY 2025 Earnings Guidance

Integer (NYSE:ITGR) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 5.840-6.200 for the period, compared to the consensus estimate of 6.070. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of research reports. KeyCorp upped their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Citigroup lifted their price objective on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Truist Financial raised their target price on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Stock Down 3.3 %

NYSE:ITGR traded down $4.66 during trading hours on Thursday, hitting $138.56. The stock had a trading volume of 285,768 shares, compared to its average volume of 230,249. The business has a 50 day simple moving average of $137.98 and a two-hundred day simple moving average of $132.28. Integer has a 1-year low of $97.49 and a 1-year high of $146.36. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The company has a market cap of $4.65 billion, a PE ratio of 42.77, a price-to-earnings-growth ratio of 1.80 and a beta of 1.13.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.70% and a return on equity of 11.63%. Analysts predict that Integer will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.